Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes-Reference-Cited by-同舟云学术

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes

Published:2009-11 Issue:1 Volume:207 Page:213-219
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Fadini Gian Paolo,de Kreutzenberg Saula,Agostini Carlo,Boscaro Elisa,Tiengo Antonio,Dimmeler Stefanie,Avogaro Angelo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Association of hyperlipidemia, diabetes mellitus and moderate obesity;Avogaro;Acta Diabetol Lat,1967

2. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung, and Blood Institute Scientific Statement;Grundy;Circulation,2005

3. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes;Kahn;Diabetes,2005

4. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men;Lakka;JAMA,2002

5. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies;Gami;J Am Coll Cardiol,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes;American Journal of Physiology-Heart and Circulatory Physiology;2024-08-01

2. Cluster of differentiation molecules in the metabolic syndrome;Clinica Chimica Acta;2024-07

3. Association between underweight, serum albumin levels, and height loss in the Japanese male population: a retrospective study;Journal of Physiological Anthropology;2024-05-27

4. Bone marrow vasculature advanced in vitro models for cancer and cardiovascular research;Frontiers in Cardiovascular Medicine;2023-10-17

5. Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells;Diabetologia;2023-09-15